Piramal Pharma (BOM:543635) Other Stockholders Equity : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Other Stockholders Equity?

Piramal Pharma's Other Stockholders Equity for the quarter that ended in Dec. 2024 was ₹0 Mil.

Piramal Pharma's quarterly Other Stockholders Equity increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹65,840 Mil) but then declined from Sep. 2024 (₹65,840 Mil) to Dec. 2024 (₹0 Mil).

Piramal Pharma's annual Other Stockholders Equity increased from Mar. 2022 (₹55,107 Mil) to Mar. 2023 (₹55,802 Mil) and increased from Mar. 2023 (₹55,802 Mil) to Mar. 2024 (₹65,884 Mil).

Piramal Pharma Other Stockholders Equity Historical Data

The historical data trend for Piramal Pharma's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Other Stockholders Equity Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Other Stockholders Equity

-7,125.10

55,106.90

55,801.80

65,884.20

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial										-	65,884.20	-	65,840.30	-

Piramal Pharma Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Piramal Pharma Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (BOM:543635) » Definitions » Other Stockholders Equity

Traded in Other Exchanges

PPLPHARMA:India

Address

Kamani Junction, LBS Marg, Ground Floor, Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd is a pharmaceutical company, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and international distribution network. It operates under three business verticals; an integrated contract development and manufacturing (CDMO) business providing Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), biologics, and vaccines among other products; the other two business verticals include a complex hospital generics business, and an India consumer healthcare business, selling over-the-counter products in India. Geographically, the company generates maximum revenue from North America and the rest from Europe, India, Japan, and other markets.

Piramal Pharma Headlines

No Headlines